Leaderboard

En | De
No articles selected!     View Cart  
You are here: Gastroenterology » Liver » Neoplasms 25. December 2025
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Hepatitis
Liver Cirrhosis
Neoplasms
Portal Hypertension
Others
Gastrointestinal
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3738  Previews Next
   
   Articles 1 - 20 / 74752  
   
Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
Curr Oncol
Minamiguchi K, Irizato M, Nakano R, Kunichika H, Tachiiri T, Taiji R, Tsuji Y, Yasuda S, Yoshiji H, Sho M, Tanaka T.
PMID: 41440222 [PubMed - indexed for MEDLINE]


Important Role of Bacterial Metabolites in Development and Adjuvant Therapy for Hepatocellular Carcinoma.
Curr Oncol
Ye G, Zhang H, Feng Q, Xiao J, Wang J, Liu J.
PMID: 41440201 [PubMed - indexed for MEDLINE]


Hepatoblastoma Cell Lines: Past, Present and Future.
Cells
Prochownik EV, Henchy CM, Wang H.
PMID: 41440033 [PubMed - indexed for MEDLINE]


Cancer stem cells in hepatocellular carcinoma: therapy resistance and emerging treatments.
Front Immunol
Yadav DK, Yadav RK, Singh A, Huang Y, Bao D, Yang Z, Huang H, Jiang Y, Wang P, Lin S, Hua Y, Hu Y.
PMID: 41438763 [PubMed - indexed for MEDLINE]


Gut microbiome, a novel precision medicine biomarker for hepatocellular carcinoma.
Front Immunol
Chen PJ, Devkota S, Shiao S, Hendifar A, Yang JD.
PMID: 41438742 [PubMed - indexed for MEDLINE]


Antitumor Effects of Tumor-Derived Exosomes in Murine Hepatocellular Carcinoma Models.
Iran J Immunol
Xu W, Fan L.
PMID: 41432120 [PubMed - indexed for MEDLINE]


Long-Term Prognostic Significance of TACE-Induced Complete Pathological Response in Patients with Hepatocellular Carcinoma Who Have Undergone Liver Transplantation.
Ann Transplant
Jeong IJ, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Park GC, Kang WH, Yoon YI, Lee SG.
PMID: 41431134 [PubMed - indexed for MEDLINE]


Efficacy and safety of sintilimab plus a bevacizumab biosimilar combined with transarterial chemoembolization for advanced hepatocellular carcinoma.
Medicine (Baltimore)
Yang J, Xu Q, Wu S.
PMID: 41431101 [PubMed - indexed for MEDLINE]


Causal role of immunophenotypes in hepatocellular carcinoma: A Mendelian randomization study.
Medicine (Baltimore)
Ou D, Huo J.
PMID: 41431046 [PubMed - indexed for MEDLINE]


An integrated chemokine-based machine learning model predicts prognosis and guides immunotherapy in hepatocellular carcinoma.
Medicine (Baltimore)
Zhou J, Liu J, Wei X, Liu C, Gu H.
PMID: 41431005 [PubMed - indexed for MEDLINE]


Deep learning for hepatocellular carcinoma segmentation in MRI: A systematic review of models, performance, and challenges.
Medicine (Baltimore)
Elhaie M, Koozari A, Arjmandi M, Najafizade N.
PMID: 41430967 [PubMed - indexed for MEDLINE]


Deep learning-based MRI model for predicting P53-mutated hepatocellular carcinoma.
BMC Med Imaging
Jia L, Yang Q, Jiang H, Huang G, Wang Z, Guo X, Li J, Xu H, Lei J.
PMID: 41430161 [PubMed - indexed for MEDLINE]


Construction and validation of a novel model for guiding targeted combined immunotherapy in advanced hepatocellular carcinoma.
Sci Rep
Tu H, Feng S, Chen L, Huang Y, Zhang J, Peng S, Lin D, Ye X.
PMID: 41429838 [PubMed - indexed for MEDLINE]


Dihydroartemisinin: A Promising Therapeutic Agent Against the Hepatitis-to-Hepatocellular Carcinoma Cascade.
Drug Des Devel Ther
Wang T, Jiang W, Li J, Ma J, Zhang Y, Zheng J, Chen J, Wen Y, Ma X, Zeng J.
PMID: 41425491 [PubMed - indexed for MEDLINE]


Progress in the Application of Nanobiotechnology in the Ablation Therapy of Hepatic Carcinoma.
Int J Nanomedicine
Gao Z, Yao L, Wei X, Wang S, Cao W, Deng W, Li X, Zhang Z, Wang S, Zhang Y, Li M, Xie Y.
PMID: 41424453 [PubMed - indexed for MEDLINE]


Exosomal circRNAs in hepatocellular carcinoma: Implications for the development and therapeutic resistance of hepatocellular carcinoma (Review).
Int J Oncol
Liu Z, Wang Y, Wang Y, Zhang Y.
PMID: 41416448 [PubMed - indexed for MEDLINE]


Integrated Genetic Information of Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Traits Improves Hepatocellular Carcinoma Risk Stratification and Screening.
JCO Precis Oncol
Du M, Wu T, Yuan H, Zhang T, Liu Z, Chen X.
PMID: 41411614 [PubMed - indexed for MEDLINE]


Efficacy and safety of Atezolizumab plus Bevacizumab and Lenvatinib as first-line systemic therapies for hepatocellular carcinoma: A real-world study.
PLoS One
Boonkaya S, Pattarawongpaiboon C, Thaimai P, Ananchuensook P, Sriphoosanaphan S, Tanasanvimon S, Teeyapun N, Pakvisal N, Siripon N, Treeprasertsuk S, Komolmit P, Thanapirom K.
PMID: 41411278 [PubMed - indexed for MEDLINE]


Dual-Contrast Agent Liver MRI for Liver Lesion Characterization.
Radiographics
Shetty AS, Ludwig DR, Fraum TJ, Lanier MH, Hoegger MJ, Rajput MZ, Tsai R.
PMID: 41411165 [PubMed - indexed for MEDLINE]


Spatial patterns and prognostic relevance of CD1a(+) immature and CD208(+) mature dendritic cells in colorectal cancer from non-tumor adjacent mucosa to liver metastases.
Cancer Immunol Immunother
Pavlov S, Ali E, Ye W, , Ambrozkiewicz F, Vy, Daum O, Li, Hemminki K, Trailin A.
PMID: 41410751 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 74752    Page 1 of 3738  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1